Wolverine Asset Management’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
2023
Q1
$14.4M Buy
2022
Q4
$1.44M Sell
2022
Q3
$1.4M Buy
2020
Q3
Sell
2020
Q2
$3.58M Buy